Kiin Bio operates as an AI-native platform that unifies drug discovery tools.
Kiin Bio has raised $2.2M in total funding. The most recent round was Pre-Seed. The last funding was announced in June 2025.
Kiin Bio's investors include Heartfelt Capital, b2venture, rule30.
Kiin Bio is headquartered in London, United Kingdom.
Kiin Bio operates as an AI-native platform that unifies drug discovery tools.
Kiin Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kiin Bio — Funding & Investors." VCBacked, June 5, 2025, https://www.vcbacked.co/company/kiin-bio. Accessed August 14, 2026.
VCBacked. (2025). Kiin Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/kiin-bio
{{cite web |title=Kiin Bio — Funding & Investors |url=https://www.vcbacked.co/company/kiin-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated